课题基金 / 基金详情

Randomized controlled trial on risk adapted damage control orthopedic surgery of femur shaft fractures in multiple trauma patients

Randomized controlled trial on risk adapted damage control orthopedic surgery of femur shaft fractures in multiple trauma patients
多发伤患者股骨干骨折风险适应损伤控制骨科手术的随机对照试验
批准号:
34242345
负责人:
Professor Dr. Dieter Rixen
金额:
$0.0万
依托单位国家:
德国
项目类别:
Clinical Trials
财政年份:
2007
资助国家:
德国
项目状态:
已结题
起止时间:
2006-12-31 至 2008-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Trauma is a major and economical issue of health care systems today and the leading cause of death up to an age of 45 years. The World Health Organization assumes that death caused by accidents, violence, and war will even increase till 2020. Fractures of the long bones and femur fractures in particular are common in multiple trauma patients, but the optimal management of femur fractures in these patients is not yet resolved. In principle, there are five methods for the treatment of these fractures: cast, extension, external fracture fixation by fixateur externe, and internal fixation with either intramedullary nail or plate osteosynthesis. This trail investigates the differences in clinical outcome and immune status of two different ways of treating multiple trauma patients with femoral shaft fractures. It is set up as a multicenter, randomized, controlled trial. The first treatment is “risk adapted damage control surgery” = “experimental group”, which consits of primary stabilization with a fixateur externe within 48 hours after trauma and secondary delayed definitive treatment with reamed intramedullary nailing. The second treatment = “control group” is primary reamed intramedullary nailing. These two procedures will be examined concerning the severity of organ failure (SOFA score as primary endpoint), the rate of complications, length of stay, the immune status of the patients, cost effectiveness, and quality of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
槲皮素控释系统调控Mettl3/Per1修复氧化应激损伤促牙周炎骨再生及机制研究
  • 批准号:
    82370921
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    徐袁瑾
  • 依托单位:
肿瘤翻译调控蛋白调控大肠癌细胞转移能力的信号机制研究
  • 批准号:
    81000952
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    马强
  • 依托单位:
多肽树状物为载体的抗癌前体药物的合成和研究
植物病毒壳体"智能"纳米载体靶向肿瘤细胞的研究
  • 批准号:
    30973685
  • 项目类别:
    面上项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2009
  • 负责人:
    曾庆冰
  • 依托单位: